VitVio Brings AI Surgical Operating System to Poland in First Central European Deployment

VitVio, a US‑European startup founded in 2024, is deploying its Vetro AI surgical operating system in Poland for the first time via a partnership with the University Clinical Centre in Gdańsk. The pilot will equip several operating rooms with cameras and sensors to create a real‑time 3D model of the surgical environment, aiming to automate documentation, reduce delays and free clinicians from paperwork. The rollout follows earlier deployments in the US, UK, Mexico and other European markets, and comes as the company finalises an $8 million seed round.

UK Healthtech Startup Stride Raises £4.6 Million to Expand Preventative Health Platform

UK‑based healthtech startup Stride secured £4.6 million in seed capital from a group of investors including Arāya Ventures and Innovate UK to expand its DNA, blood and gut‑testing based preventative health platform and prepare for international rollout by the end of 2026.

Cambridge RNA Therapeutics Startup Undecimal Bio Raises €16 Million to Expand AI-Powered Delivery Platform

Cambridge‑based spin‑out Undecimal Bio secured €16 million in Seed funding, co‑led by 4BIO Capital and IQ Capital, to develop its AI‑driven DELiveri platform that identifies conjugates for precise siRNA delivery to non‑liver tissues, starting with renovascular diseases.

London-based Scarlet raises $50M Series B to expand AI medical device certification globally

Scarlet, a London‑based certification body specialized in AI and software medical devices, closed a $50 million Series B led by Headline. The funding will support its expansion into the US and APAC markets, increase its team of AI reviewers, and extend its certification services, positioning it as the only EU‑designated notified body focused on AI‑native medical devices.

Italian Neuro-Wellness Startup Spherison Closes €500k Seed Round to Pursue Medical Certification and U.S. Expansion

Spherison, an Italian neuroscience startup that commercialises a patented “esanaurale” binaural‑beat technology for neuro‑wellness, has closed a €500k seed round (after a €150k pre‑seed from Federico Faggin). The capital will support medical‑device certification, U.S. market entry and further scaling. The company already has about 100 installations across Italy and Switzerland and is conducting clinical studies with several universities and hospitals.